Published on Roswell Park Cancer Institute (http://www.roswellpark.org)

Director of Collaborative Research
Associate Professor of Oncology
Roswell Park Cancer Institute
Research Associate Professor
Department of Social and Preventative Medicine, School of Public Health, SUNY at Buffalo, NY
Research
Selected Publications: 

Book Chapters

1. Reid ME.  Cancer Control and Epidemiology, Cancer Nursing, Yarbro CH(ed), Jones & Bartlett, Boston MA.  Editions 1993, 1997, 1999.

2. Loescher L, Reid ME.  Dynamics of Cancer Prevention, Cancer Nursing, Yarbro CH (ed), Jones & Bartlett, Boston MA.  Editions 1993, 1997, 1999.

3. Marshall JR, Reid ME.  Trials and Interventions. In: Molecular Epidemiology: Applications in Cancer and Other Human Diseases (Rebbeck T, Ambrosone CA, Shields P, Eds.).  New York: Informa Healthcare, Chapter 3, pp. 29-40, 2008.

4. Mazzilli S, Reid M, Foster BA.  Cancer Prevention with Vitamin D.  In “Vitamin D and Cancer” (Trump DL & Johnson CS, Eds) Springer Publishers; pp 175-189. 2011.

Original Peer-Reviewed Articles

1.  Clark LC, Hixson LJ, Combs GF, Reid ME, Turnbull BW, Sampliner RE.  Plasma Selenium Concentration Predicts the Prevalence of Colorectal Adenomatous Polyps, Cancer, Epidemiology Biomarkers & Prevention, 2: 41-46, 1993.

2.  Martinez ME, Reid ME, Guillen-Rodriguez J, Marshall JR, Sampliner R, Aickin M, Ritenbaugh C, van Leeuwen B, Mason-Liddil N, Giuliano A, Vargas PA, Alberts DS.  Design and baseline characteristics of study participants in the wheat bran fiber trial.  Cancer, Epidemiology Biomarkers & Prevention, 7: 813-816, 1998.

3.  Martinez ME, Maltzman T, Marshall JR, Einspahr J, Reid ME, Sampliner R, Ahnen D, Hamilton SR, Alberts DS.  Risk of K-ras Protooncogene Mutation in Sporadic Colorectal Adenomas.  Cancer Research, 59(20): 5181-5, 1999.

4.  Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez J, Marshall JR, van Leeuwen B, Reid ME, Ritenbaugh C, Parish D, Koonce K, Fales L, Vargas P, Bhattacharyya A, Earnest DL, Sampliner R.  Lack of Effect of High Fiber Cereal Supplement on Colorectal Adenoma Recurrence: the Wheat Bran Fiber Study. New England Journal of Medicine, 342(16): 1156-62, 2000.

5.  Martinez ME, Sampliner R, Bhattacharyya AB, Marshall JR, Reid ME, Alberts DS.  Adenoma Characteristics as Risk Factors for Recurrence of Advanced Adenomas. Gastroenterology, 120:1077-1083, 2001

6.            Maltzman T, Knoll K, Martinez ME, Byers T, Stevens BR, Marshall JR, Reid ME, Einspahr J, Hart N, Bhattacharyya AK, Kramer CB, Sampliner R, Alberts DS, Ahnen DJ.  Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology, 2001 Aug; 121(2):302-9.

7.  Nelson MA, Reid ME, Duffield-Lillico AJ, Marshall JR. Prostate Cancer and Selenium, Urological Clinics of North America, 2001.

8.  Lillico AJ, Reid ME, Turnbull BW, Combs GF, Slater EH. Clark LC, Marshall JR.  Total Cancer Incidence and Selenium Supplementation.  CEBP, 11: 630-639, 2002.

9.  Reid ME, Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR.  Lung cancer incidence and selenium supplementation: an update of a clinical trial. CEBP, 11(11): 1285-1291, 2002.

10. Moysich KB, Menezes RJ, Ronsani A, Swede H, Reid ME, Cummings KM, Falkner KL, Loewen GM and Bepler G. Regular Aspirin Use and Lung Cancer Risk.  BMC Cancer, 2:31, 2002.

11. Marshall JR, Reid ME, Lillico AJ. Letter to the Editor.  CEBP, 12: 78, 2002.

12. Lillico A, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Combs GF, Marshall JR, Clark LC. Selenium supplementation, baseline plasma selenium status, and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.  BJU, 91: 608-612, 2002.

13. Lillico AJ, Slate E, Reid ME, Turnbull BW, Wilkins PA, Combs GF, Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC.  Selenium Supplementation and the Secondary Prevention of Non-Melanoma Skin Cancer in a Randomized Trial.  JNCI, 95(19): 1477-81, 2003.

14. Stratton MS, Reid ME, Minter F, Schwartzberg G, Monroe BK, Alberts DS, Marshall JR, Ahmann FR. Selenium and prevention of cancer in high-risk men: the Negative    Biopsy Study. Anticancer Drugs, 14(8): 589-594, 2003.

15. Stratton MS, Reid ME, Minter F, Schwartzberg G, Monroe BK, Alberts DS, Marshall JR, Ahmann FR.   Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the “Watchful Waiting” Study. Anticancer Drugs, 14(8):595-600, 2003.

16. Reid ME, Marshall JR, Roe D, Lebowitz M, Alberts DS, Battacharyya AK, Martinez ME.  Smoking Exposure as a Risk Factor for Prevalent and Recurrent Colorectal Adenomas. CEBP, 12: 1006-1011, 2003.

17. Larsen EH, Hansen M, Paulin H, Moesgaard S, Reid ME, Rayman M.  Speciation and bioavailability of selenium in yeast-based intervention agents used in cancer chemoprevention studies.  JAOAC, 87(1): 225-231, 2004.

18. Swede H, Dong Y, Reid ME, Marshall JR, Ip C.  Cell Cycle Arrest Biomarkers in Human Lung Cancer Cells After Treatment with Selenium in Culture. CEBP, 12: 1248-1252, 2003.

19. Martinez ME, Reid ME, Jiang R, Alberts DS. Accuracy of Self-reported Smoking Status and Assessment of Quit Rate Among Participants in a Chemoprevention Trial. Preventive Medicine, 38: 492-497, 2004

20. Loewen, GM, Reid ME, Tan DF, Klippenstein DL, Grossman ZD, Nava E, Hyland AJ, Cummings MK, Mahoney MC. Bimodality Lung Cancer Screening in High Risk Patients (Expanded Abstract).  Chest, 125(5 Suppl):163S-4S, 2004.

21. Hess LM, Krutzsch  MK, Guillen J, Sherry Chow HH, Einspahr J, Batta AK, Salen G, Reid ME, Earnest DL, Alberts DS.  Results of a Phase I Multiple-Dose Clinical Study of Ursodeoxycholic Acid (UDCA).  CEBP, 13(5):861-867, 2004.

22. Marshall JR, Reid ME, Lillico AJ. Response to Letter to the Editor. JNCI, 96(4), 2004.

23. Chang S, Buist DSM, Reid M, Terry MB, Trentham-Dietz A. The Characteristics and Training of Professionals in Cancer Prevention and Control: a Survey of the American Society for Preventive Oncology (ASPO). CEBP, 13:1094-1098, 2004.

24. Jacobs ET, Giuliano AR, Martinez ME, Hollis BW, Reid ME, Marshall JR. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D3 and the risk of prostate cancer.  Journal of Steroid Biochemistry & Molecular Biology, 90(1-5): 533-7, 2004.

25. Reid ME, Stratton MS, Lillico AJ, Fakih M, Natarajan R, Marshall JR. Evaluation of Toxicity from Short-term High Dose Selenium Supplementation. Journal of Trace Elements in Medicine and Biology, 18: 69-74, 2004.

26. Jacobs ET, Jiang R, Alberts DS, Greenberg ER, Gunter EW, Karagas MR, Lanza E, Ratnasinghe L, Reid ME, Shatzkin A, Smith-Warner SA, Wallace K, Martinez ME.  Selenium and Colorectal Andonoma: Results from a Pooled Analysis, JNCI, 96: 1669-75, 2004.

27*. Hutson, A, Reid ME. The Utility of Partial Cross-Over Designs in Early Phase Randomized Prevention Trials, Controlled Clinical Trials, 25: 493-501, 2004.

28. Baker JA, McCann SE, Reid ME, Nowell S, Beehler GP, and Moysich KB. Associations between black tea and coffee consumption and risk of lung cancer among smokers. Nutrition and Cancer, 52(1):15-21, 2005.

29. Baker JA, Odunuga OO, Rodabaugh KJ, Reid ME, Menezes RJ, Moysich KB.  Active and passive smoking and risk of ovarian cancer. International Journal of Gynecological Cancer, 16 Suppl 1:211-8, 2006.

30. Reid ME, Duffield-Lillico AJ, Sunga A, Fakih M, Alberts DS, Marshall JR.  Selenium Supplementation and Colorectal Adenomas: An Analysis of the Nutritional Prevention of Cancer Trial, Int J Cancer, 118(7): 1777-1781, 2006.

31. Fakih M, Ip C, Reid ME, Sunga A, Rustum Y.  Selenium Supplementation: Protection against Chemotherapy-Induced Toxicity and Enhancement of Antitumor Activity? Supportive and Palliative Cancer Care, 2: 3-9, 2005.

32. Fakih MG, Pendyala L, Smith PF, Creaven PJ, Reid ME, Badmaev V, Azrak RG, Prey JD, Lawrence D, Rustum YM. A Phase I and Pharmacokinetic Study of Fixed Dose Selenomethionine and Irinotecan in Solid Tumors, CCR, 15; 12(4):1237-44, 2006.

33*. Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, Farinaro E, Clark LC, Reid ME.  Effects of Selenium Supplementation on Cardiovascular Disease Incidence and Mortality: Secondary Analyses in a Randomized Clinical Trial, AJE, 163: 694 – 699, 2006.

34. Jayaprakash V, Menezes RJ, Javle MM, McCann SE, Baker JA, Reid ME, Natarajan N, Moysich KB. Regular aspirin use and esophageal cancer risk.  Int J Cancer, 119(1):202-7, 2006.

35*. Jayaprakash V, Rigual N, Moysich KB, Loree T, Sullivan Nasca M, Menezes RJ, Reid ME. Chemoprevention of Head and Neck Cancer with Aspirin: A Case-Control Study. Arch of Otolaryngology, 132:1231-1236, 2006.

36. Tezal M, Sullivan MA, Reid ME, Marshall JR, Hyland A, Hausmann E, Loree T, Lillis C,   Hauck L, Wactawski-Wende J, Scannapieco FA.  Chronic Periodontitis and the Risk of Tongue Cancer. Arch of Otolaryngology, 133 (5): 450-4, 2007.

37*. Frankel P, Marshall JR, Reid ME. A Permutation Test for a Weighted Kaplan-Meier Estimator with Application to the Nutritional Prevention of Cancer Trial.  Contemporary Clinical Trials, 28(4): 343-7, 2007.

38*. Loewen GL, Natarajan N, Tan DF, Nava E, Klippenstein D, Mahoney M, Cummings M, Reid ME. Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment.  Thoracic, 62(4): 335-40, 2007.

39*. Ramnath N, Demmy T, Antun A, Natarajan N, Nwogu C, Loewen GL, Reid ME.  Pneumonectomy for Bronchogenic Carcinoma: Analysis of Factors Predicting Survival.  Annals of Thoracic Surgery, 83(5): 1831-6, 2007.

40*. Kuehnelt D, Juresa D, Francesconi KA, Fakih M, Reid ME. Selenium metabolites in urine of cancer patients receiving L-selenomethionine at high doses.  Toxicology and Applied Pharmacology, 220(2): 211-5, 2007.

41. Reid ME, Duffield-Lillico AJ, Slate E, Natarajan N, Turnbull B, Jacobs E, Combs GF, Alberts DS, Clark LC, Marshall JR. The Nutritional Prevention of Cancer: 400 mcg per day Selenium Treatment.  Nutrition and Cancer, 60(2): 155-63, 2008.

42*. Stranges S, Marshall JR, Donahue RP, Trevisan M, Natarajan R, Combs GF, Cappuccio FP, Ceriello A, Reid ME.  Effects of Long-term Selenium Supplementation on the Incidence of Type 2 Diabetes:  A Randomized Controlled Trial. Annals of Internal Medicine, 147: 217-223, 2007.

43. Pande R, Sunga A, LeVea C, Wilding GE, Bshara W, Reid ME, Fakih MG.   Significance of Signet Ring Cells in Colorectal Cancer Patients.  Disease of the Colon and Rectum.  51(1):50-5, 2008.

44. Nowak NJ, Miecznikowski J, Moore SR, Gaile D, Bobadilla D, Smith DD, Kernstine K, Forman SJ, Mwahech-Fauceglia P, Reid ME, Stoler D, Loree T, Rigual N, Sullivan MA, Weiss LM, Hicks D, Slovak ML. Challenges in array CGH for the analysis of cancer samples. Genetics in Medicine, 9(9): 585-95, 2007.

45*. Ramnath N,  Menezes RJ, Loewen G, Dua P, Eid F, Alkhaddo J, Paganelli G, Natarajan N,  Reid ME.  Hormone Replacement Therapy as a Risk Factor for Non-Small Cell Lung Cancer: Results of a Case Control Study.  Oncology, 73(5-6): 305-10, 2008.

46*.  Jayaprakash V, Natarajan K, Moysich KB, Rigual NR, Ramnath N, Natarajan N, Reid ME. Wood Dust Exposure and the Risk of Upper Aero-Digestive and Respiratory Cancers in Males. J. Occup Envir Med, Jan 8, 2008.

47. Girnun GD, Howe LR, Manne S, Mao JT, Reid ME, Szabo E.  Meeting Report:  Sixth Annual AACR International Conference on Frontiers in Cancer Prevention Research.  Cancer Prevention, 2008.

48. Peppone LJ, Mahoney MC, Cummings KM, Michalek AM, Reid ME, Moysich KB, Hyland A.  Colorectal cancer occurs earlier in those exposed to tobacco smoke: implications for screening.  J of Can Res and Clin Onc, 134(7): 743-51,2008. 

49*.  Menezes RJ, Cheney RT, Husain A, Tretiakova M, Loewen G, Johnson CS, Jayaprakash V, Moysich KB,  Salgia R, Reid ME.  Vitamin D receptor expression in normal, premalignant and malignant human lung tissue.  CEBP, 17(5): 1104-10, 2008.

50. Reid ME, Santella R, Ambrosone C. Molecular Epidemiology to Better Predict Lung Cancer Risk.  Clinical Lung Cancer, 9(3): 149-153, 2008.

51. Ailawadhi S, Derby L, Natarajan R, Fetterly G, Reid ME, Ramnath N. Erlotinib for metastatic non-small cell lung cancer: first, second or third line setting- does it matter? A single institution experience. Oncology, 76(2): 85-90, 2009.

52. Tezal M, Sullivan M, Hyland A, Marshall J, Stoler D, Reid M, Loree T, Rigual N, Merzianu M, Hauck L, Lillis C, Wactawski-Wende J, Scannapieco F. Chronic Periodontitis and the Incidence of Head and Neck Squamous Cell Carcinoma. CEBP, 18(9):2406-12, 2009.

53. Peppone LJ, Hyland A, Moysich KB, Reid ME, Piazza KM, Purnell JQ, Mustian KM, Morrow GR. Examining the association between cigarette smoking and colorectal cancer using historical case-control data.  Cancer Epidemiology, 33(3-4): 182-8, 2009.

54*. Jayaprakash V, Sullivan MA, Merzianu M, Rigual N, Loree T, Popat S, Moysich K, Ramananda S, Johnson T, Marshall JR, Hutson A, Mang T, Wilson B, Gill S, Frustino J, Bogaards A, Reid ME.  Autofluorescence Guided Surveillance of Oral Cancer.  Cancer Prevention Res, 2(11): 966-74, 2009.

55. Peppone LJ, Hebl S, Purnell JQ, Reid ME, Rosier RN, Mustian KM, Palesh OG, Huston AJ, Ling MN, Morrow GR. The efficacy of calcitriol therapy in the management of bone loss and fractures: A qualitative review.  Osteoporosis International, 2010 Jul;21(7):1133-49.

56. Tang L, Zirpoli GR, Jayaprakash V, Reid ME, McCann SE, Nwogu CE, Zhang Y, Ambrosone CB, Moysich KB.  Cruciferous Vegetable Intake Is Inversely Associated With Lung Cancer Risk Among Smokers: A Case-control Study. BMC Cancer,  April 27, 2010, 10(1): 162.

57. Bhaskarla A, Tang P, Mashtare T, Nwogu CE, Demmy TL, Adjei AA, Reid ME, Yendamuri S.  Analysis of Second Primary Lung Cancers in the Seer Database. Journal of Surgical Research, 2010 Jul;162(1):1-6. Epub 2010 Jan 25.

58. Peppone LJ. Reid ME, Moysich KB. Morrow GR, Jean-Pierre P, Mohile SG, Darling TV, Hyland A. The Effect of Secondhand Smoke Exposure on the Association between Active Cigarette Smoking and Colorectal Cancer. Cancer Causes Control, 2010 Aug;21(8):1247-55.

59. Mackinnon AC, Tretiakova M, Henderson L, Mehta RG, Yan BC, Joseph L, Krausz T, Husain AN, Reid ME, Salgia R.  Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.  J Clin Path, 2011 Jan;64(1):16-24. Epub 2010 Nov 2.

60. Platek ME, Reid ME, Wilding, GE, Wainwright J, Rigual NR, Hicks WL, Popat SR, Warren GW, Sullivan M, Thorstad WL, Khan MK, Loree TR, Singh AK.  Pre-Treatment nutritional status and loco-regional failure of head and neck cancer patients undergoing definitive concurrent chemoradiation therapy. Head & Neck, Dec 15, 2010 (Epub ahead of print PMID: 21162055)

61. Peppone LJ, Huston AJ, Reid ME, Rosier RN, Trump DL, Mustian KM, Janelsins MC, Purnell JQ, Morrow GR. The effect of various vitamin D supplementation regimens in breast cancer patients, Breast Cancer Res Treat, (In Press, 2011).

62. Jayaprakash V, Cheng C, Reid ME, Dexter E, Nwogu C, Hicks W, Sullivan M, Demmy T, Yendamuri S. Previous Head and Neck Cancers Predict Poor Prognoses in Lung Cancer Patients. ATS, 2011; 92(3): 1056-1061.

63. Jayaprakash V, Reid ME, Hatton E, Merzianu M, Rigual N, Marshall J, Gill S, Frustino J, Wilding G, Loree T, Popat S, Sullivan Nasca M. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol 2011; 47(11): 1048-1054.

64. Serfin J, Carragher J, Groman A, Dexter E, Yendamuri S, Nwogu C, Reid ME, Bogner P. Outcome Prediction Using Markers of Aerobic Glycolysis (the Warburg effect) Varies Between Tumor Regions in Stage I Non-Small Cell Lung Cancer. J Mol Biomark Diagn, 2011 Oct; 2:116.

65. Warren GW, Kasza KA, Reid ME, Michael Cummings K, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int. J. Cancer, 2012 Apr 26, doi: 10.1002/ ijc.27617. [Epub ahead of print].

66*. Jayaprakash V, Loewen G, Dhillon S, Moysich K, Mahoney M, Yendamuri S, Hogarth K, Reid ME. Early detection of lung cancer using CT and bronchoscopy in a high risk population. J Cancer Therapy, (in press).

67*. Jayaprakash V, Loewen G, Mahoney M, Dhillon S, Yendamuri S, Hogarth K, Machare-Delgado E, Reid ME. Effect of impaired lung function on the development and progression of endobronchial premalignant lesions. J Cancer Therapy, (in press).

68. Ferketich A, Niland J, Mamet R, Zornosa C, D’Amico T, Ettinger D, Kalemkerian G, Pisters K, Reid ME, Otterson G. Smoking Status and Survival in the National Comprehensive Cancer Network’s Non-Small Cell Lung Cancer Cohort. Cancer, (in press).

69*. Dhillon S, Jayaprakash V, Loewen GL, Reid ME. Lung Cancer Screening Update. Carcinogenesis, (in press).

  * = Denotes Senior Author

Background Information
Education and Training: 
PhD - Department of Epidemiology, School of Public Health, University of Arizona, Tucson, AZ
MSPH - Department of Epidemiology, Division of Public Health, University of Massachusetts, Amherst, MA
BSN - College of Nursing, Northeastern University, Boston, MA
Professional Experience: 
11/07-5/09 - Associate Professor of Oncology, Division of Cancer Prevention and Population Sciences, Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY
9/02-11/07 - Assistant Professor of Oncology, Division of Cancer Prevention and Population Sciences, Department of Epidemiology, Roswell Park Cancer Institute, Buffalo, NY
11/05-10/09 - Research Assistant Professor, Department of Social and Preventive Medicine, School of Public Health, SUNY at Buffalo, Buffalo, NY
4/04-11/09 - Assistant Professor, Department of Cancer Pathology and Prevention, Graduate College, SUNY at Buffalo, Buffalo, NY
7/01-9/02 - Assistant Professor, Division of Epidemiology and Biostatistics, College of Public Health, University of Arizona, Tucson, AZ
5/00-6/01 - Research Instructor, Division of Epidemiology and Biostatistics, College of Public Health, University of Arizona, Tucson, AZ
7/99-5/00 - Research Instructor, Arizona Prevention Center, University of Arizona, Tucson, AZ
7/98-7/02 - Co-Director, Cancer Prevention and Control Training Program, Arizona Cancer Center, University of Arizona, Tucson, AZ
9/89-9/93 - Lecturer in Epidemiology, Social and Behavioral Science Course, College of Medicine, University of Arizona, Tucson, AZ
8/95-7/99 - Research Specialist, Principal, Cancer Prevention and Control Program, Arizona Cancer Center, University of Arizona, Tucson, AZ
9/87-8/95 - Research Specialist, Principal, Project Director of the Selenium and Cancer Prevention Program, Family and Community Medicine, University of Arizona, Tucson, AZ
9/85-9/87 - Research Assistant, Division of Public Health, University of Massachusetts, Amherst, MA
6/85-9/85 - Intern, Nutritional Epidemiology, Massachusetts Department of Public Health, Statistics and Evaluations Branch, Boston, MA
Professional Memberships: 
2010 - DSMB ~ Center for Population Health and Health Disparities, OSU, Columbus, OH
2010 - NLST-ACRIN Scientific Review for Use of Biospecimens
2010 - ACCP Lung Cancer Guidelines III, Lung Cancer Chemoprevention Chapter
2010 - NCCN Lung Screening Consensus Committee Member
2010 - AACR Frontiers of Prevention Program Committee Member
2009 - NCCN, Non-Small Cell Lung Cancer Database, Local PI
2007 - International Association of the Study of Lung Cancer (IASLC), Member
2007 - Mock Study Section Member, AARC Grant Writing Workshop for Associate Members, AACR, Los Angeles, CA
2005 - CALGB Prevention Committee Member
2000 - American Society of Preventive Oncology (ASPO), Member Founding Member for Steering Committee for Junior Members Career Development
1998 - American Association for Cancer Research (AACR), Member
Publications
Publications: 
  • Bhaskarla A, Tang PC, Mashtare T, Nwogu CE, Demmy TL, Adjei AA, Reid ME, Yendamuri S. Analysis of second primary lung cancers in the SEER database. Journal of surgical research 2010; 162(1):1-6
  • Tang L, Zirpoli GR, Jayaprakash V, Reid ME, McCann SE, Nwogu CE, Zhang Y, Ambrosone CB, Moysich KB. Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study. BMC cancer 2010; 10 :162
  • Mazzilli SA, Reid ME, Foster BA, Johnson CS, Trump DL. The effects of l alpha,25-dihydroxyvitamin D3 (calcitriol) on the tumor-igenesis of lung squamous cell carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 2010; 51:460
  • Peppone LJ, Reid ME, Moysich KB, Morrow GR, Jean-Pierre P, Mohile SG, Darling TV, Hyland A. The effect of secondhand smoke exposure on the association between active cigarette smoking and colorectal cancer. Cancer causes and control : CCC 2010; 21(8):1247-1255
  • Peppone LJ, Ling MN, Huston AJ, Palesh OG, Mustian KM, Rosier RN, Reid ME, Purnell JQ, Hebl S, Morrow GR. The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review. Osteoporosis international 2010; 21(7):1133-1149
  • Warren GW , Gal T , Martella A , Marshall J , Cummings M , Reid M , Sims J , Valentino J , Arnold S , Kudrimoti M. Weekly self-reported tobacco use and cessation during definitive radiotherapy or chemoradiotherapy for head and neck cancer. International journal of radiation oncology, biology, physics 2010; 78(3 Suppl. 1):S563
  • Chadha MK, Rigual NR, Thankappan K, Jayaprakash V, Sullivan M, Reid ME, Loree TR. Induction chemotherapy for stage III/IV oral and oropharyngeal squamous cell cancers. Journal of clinical oncology 2010; 28(15 Suppl.):e16012
  • Vandergrift JL, Pisters K, Niland JC, Otterson GA, Kalemkerian GP, Ettinger DS, Rabin MS, Reid ME, Zornosa C, Mamet R, NCCN Oncology Outcomes Database Non-Small Cell Lung Cancer Disease Specific Executive Committee . First-line systemic therapy in metastatic non-small cell lung cancer (mNSCLC) patients treated at National Comprehensive Cancer Network (NCCN) institutions: An analysis from the NCCN Oncology Outcomes Database Project. Journal of clinical oncology 2010; 28(15 Suppl.):7634
  • Zornosa C, Pisters K, Niland JC, Hayman J, Rabin MS, Otterson GA, Ettinger DS, Reid ME, Mamet R, NCCN Oncology Outcomes Database Non-Small Cell Lung Cancer Disease-Specific Executive Committee. Utilization of adjuvant therapy among completely resected non-small cell lung cancer (NSCLC) patients in the National Comprehensive Cancer Network (NCCN) Outcomes Database Project. Journal of clinical oncology 2010; 28(15 Suppl.):7017
  • Ailawadhi S, Derby L, Natarajan R, Fetterly G, Reid M, Ramnath N. Erlotinib for metastatic non-small-cell lung cancer: first-, second- or third-line setting - does it matter ? A single-institution experience. Oncology 2009; 76(2):85-90
  • Jayaprakash V, Bogaards A, Frustino J, Gill SR, Wilson BC, Mang TS, Hutson AD, Marshall JR, Johnson T, Ramananda S, Moysich KB, Popat SR, Loree TR, Rigual NR, Merzianu M, Sullivan M, Reid ME. Autofluorescence-guided surveillance for oral cancer. Cancer prevention research (Philadelphia, Pa.) 2009; 2(11):966-974
  • Peppone LJ, Hyland A, Moysich KB, Reid ME, Piazza KM, Purnell JQ, Mustian KM, Morrow GR. Examining the association between cigarette smoking and colorectal cancer using historical case-control data. Cancer epidemiology 2009; 33(3-4):182-188
  • Tezal M, Wactawski-Wende J, Lillis C, Hauck L, Merzianu M, Rigual NR, Loree TR, Reid ME, Stoler D, Marshall JR, Hyland A, Sullivan MA, Scannapieco FA. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer epidemiology, biomarkers and prevention 2009; 18(9):2406-2412
  • Ferketich AK, Reid ME, Pisters KM, Kalemkerian GP, Ettinger DS, D'Amico TA, Zornosa C, Mamet R, Niland JC, Otterson GA. Survival among smokers and nonsmokers in the National Comprehensive Cancer Network (NCCN) Non-small Cell Lung Cancer (NSCLC) Cohort. Journal of thoracic oncology 2010; 5(12 Suppl. 7):S513
  • Mackinnon AC, Reid ME, Husain AN, Krausz T, Joseph L, Yan BC, Mehta RG, Henderson L, Tretiakova M, Salgia R. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease. Journal of clinical pathology 2011; 64(1):16-24
  • Peppone LJ, Purnell JQ, Janelsins MC, Mustian KM, Trump DL, Zakharia Y, Rosier RN, Reid ME, Huston AJ, Morrow GR. The effect of various vitamin D supplementation regimens in breast cancer patients. Breast cancer research and treatment 2011; 127(1):171-177
  • Jayaprakash V, Natarajan KK, Moysich KB, Rigual NR, Ramnath N, Natarajan N, Reid ME. Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males. Occupational and environmental medicine 2008; 65(10):647-654
  • Pande R, Sunga A, Levea C, Wilding GE, Bshara W, Reid M, Fakih MG. Significance of signet-ring cells in patients with colorectal cancer. Diseases of the colon and rectum 2008; 51(1):50-55
  • Peppone LJ, Mahoney MC, Cummings KM, Michalek AM, Reid ME, Moysich KB, Hyland A. Colorectal cancer occurs earlier in those exposed to tobacco smoke: implications for screening. Journal of cancer research and clinical oncology 2008; 134(7):743-751
  • Reid ME, Clark LC, Alberts DS, Combs GF Jr, Jacobs E, Turnbull B, Natarajan N, Slate E, Duffield-Lillico AJ, Marshall JR. The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutrition and cancer 2008; 60(2):155-163
  • Reid ME, Santella R, Ambrosone CB. Molecular epidemiology to better predict lung cancer risk. Clinical lung cancer 2008; 9(3):149-153
  • Frankel PH, Reid ME, Marshall JR. A permutation test for a weighted Kaplan-Meier estimator with application to the nutritional prevention of cancer trial. Contemporary clinical trials 2007; 28(4):343-347
  • Kuehnelt D, Juresa D, Francesconi KA, Fakih M, Reid ME. Selenium metabolites in urine of cancer patients receiving L-selenomethionine at high doses. Toxicology and applied pharmacology 2007; 220(2):211-215
  • Loewen G, Natarajan N, Tan D, Nava E, Klippenstein D, Mahoney M, Cummings M, Reid M. Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax 2007; 62(4):335-340
  • Nowak NJ, Hicks D, Weiss LM, Sullivan M, Rigual N, Loree T, Stoler D, Reid M, Mhawech-Fauceglia P, Forman SJ, Kernstine K, Smith DD, Bobadilla D, Gaile D, Moore SR, Miecznikowski J, Slovak ML. Challenges in array comparative genomic hybridization for the analysis of cancer samples. Genetics in medicine 2007; 9(9):585-595
  • Ramnath N, Demmy TL, Antun A, Natarajan N, Nwogu CE, Loewen GM, Reid ME. Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting survival. Annals of thoracic surgery 2007; 83(5):1831-1836
  • Ramnath N, Menezes RJ, Loewen G, Dua P, Eid F, Alkhaddo J, Paganelli G, Natarajan N, Reid ME. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study. Oncology 2007; 73(5-6):305-310
  • Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, Reid ME. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Annals of internal medicine 2007; 147(4):217-223
  • Faoro L, Krausz T, Armato SG 3rd, Reid ME, Cheney RT, Ferguson MK, El-Zayaty SA, Salgia R, Hutto JY, Husain AN. Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma. Archives of pathology and laboratory medicine 2008; 132(12):1882-1888
  • Menezes RJ, Salgia R, Moysich KB, Jayaprakash V, Johnson CS, Loewen G, Tretiakova M, Husain A, Cheney RT, Reid ME. Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue. Cancer epidemiology, biomarkers and prevention 2008; 17(5):1104-1110
  • Tezal M, Wactawski-Wende J, Hauck L, Lillis C, Loree T, Hyland A, Marshall JR, Reid ME, Sullivan MA, Scannapieco FA. Chronic periodontitis and the risk of tongue cancer. Archives of otolaryngology--head and neck surgery 2007; 133(5):450-454
  • Jayaprakash V, Cheng C, Reid M, Dexter EU, Nwogu CE, Hicks W, Sullivan M, Demmy TL, Yendamuri S. Previous head and neck cancers portend poor prognoses in lung cancer patients. Annals of thoracic surgery 2011; 92(3):1056-1061
  • Mazzilli SA, Reid ME, Foster BA, Trump DL, Johnson CS. The effects of vitamin D on the tumorigenesis of lung squamous cell carcinoma in a carcinogen incduced mouse model. Journal of thoracic oncology 2011; 6(6 Suppl. 2):S939-S940
  • Bickel KE, Niland JC, Mamet R, Zornosa CC, Ettinger DS, Pisters K, Otterson GA, Koczywas M, Reid ME, Rabin MS, D'Amico TA, Earle C, Pini TM, Kalemkerian GP. Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):7537
  • Cummings KM, Hyland A, Zevon M, Kelly M, Long MA, Demmy TL, Dexter E, Reed R, Epstein J, Houston T, Jenkins D, Mahoney M, O'Connor R, Marshall JR, Reid ME, Smith JL, Chmura M, Warren GW. An institutional universal standardized tobacco use assessment and intervention in cancer patients : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):e16543
  • Warren GW, Kasza K, Reid ME, Cummings KM, Marshall JR. Prospective structured smoking behavior assessment at diagnosis and long-term cancer survival : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):1557
  • Feser WJ, Baron AE, Wolf HJ, Jayaprakash V, Reid M, Keith RL, Kennedy TC, Hirsch FR, Franklin WA, Miller YE, Byers T. Analysis of bronchial histology and incident lung cancer - a prospective approach. Journal of thoracic oncology 2009; 4(9 Suppl. 1):S490-S491
  • Franklin WA, Crichton D, Reid M, Mattmann C, Hart A, Deng D, Chesnut P, Logue B, Stelling D, Varella-Garcia M, Kennedy TC, Miller YE. A distributed bronchial mapping software tool for the tracking of cellular, molecular and imaging results in the central airways. Journal of thoracic oncology 2009; 4(9 Suppl. 1):S339
  • Ghadersohi A, Bogner PN, Fayazi Z, Demmy TL, Reid M, Wilding G, Reska N, Slocum H, Groth J, Azrak RG, Rustum YM, Li F. Downregulation of PDEF expression in lung carcinoma is associated with up regulation of survivin and malignant potential. Proceedings of the American Association for Cancer Research Annual Meeting 2007; 48:797
  • Mackinnon A, Tretiakova M, Manaligod J, Krausz T, Husain A, Cheney R, Reid M, Salgia R. Paxillin in non-small cell lung cancer (NSCLC) development and progression: immunohistochemical, molecular, and epidemiological analysis of transbronchial biopsies from high-risk patients. Histopathology 2008; 53:813
  • Mang T, Sullivan-Nasca M, Reid M, Rigual N, Jayaprakash V, Menezes R, Loree T. Autofluorescence detection of oral malignancies. Oral oncology 2007; 2(Suppl.):121
  • Reid ME, Jayaprakash V, Menezes R, Natarajan R, Loewen G. The prevalence and persistence of premalignant lesions: a report of a high risk lung cancer cohort. Journal of thoracic oncology 2007; 2(8 Suppl.):S331-S332
  • Santella RM, Zhang YJ, Wang Q, Redman M, Chansky K, Reid M, Davis W, Gandara D, Powell CA, Albain K, Ambrosone C. Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposure. Journal of thoracic oncology 2009; 4(9 Suppl. 1):S164
  • Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Cappuccio FP, Combs GF, Clark LC, Reid ME. Effects of selenium supplementation on type 2 diabetes incidence: Secondary analyses in a randomized clinical trial. Circulation 2007; 115(8):E226
  • Sunga AY, Levea C, Fakih M, Reid M, Mahoney M, Smith J, Trump D, Johnson C, Schiff M. Aberrant crypt foci characterization in selected colorectal cancer risk groups. Proceedings of the American Association for Cancer Research Annual Meeting 2007; 48:397
  • Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J, Gill S, Frustino J, Wilding G, Loree T, Popat S, Sullivan M. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral oncology 2011; 47(11):1048-1054
  • Platek ME, Reid ME, Wilding GE, Jaggernauth W, Rigual NR, Hicks WL Jr, Popat SR, Warren GW, Sullivan M, Thorstad WL, Khan MK, Loree TR, Singh AK. Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head and neck 2011; 33(11):1561-1568
  • Lepisto EM, Vandergrift JL, Kalemkerian GP, Pisters KM, Zornosa C, Rabin MS, Reid ME, Koczywas M, Otterson GA, Ettinger DS. Oncology Medication Utilization Based On Federal Drug Administration (FDA) Labeling, National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline (GL) Recommendations, and Evidence for Patients with Advanced Non Small Cell Lung Cancer (NSCLC): An Analysis From the NCCN Oncology Outcomes Database. Value in health 2011; 14(3):A176-A177
  • Wood DE, Eapen GA, Ettinger DS, Hou L, Jackman D, Kazerooni E, Klippenstein D, Lackner RP, Leard L, Leung ANC, Massion PP, Meyers BF, Munden RF, Otterson GA, Peairs K, Pipavath S, Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Schabath MB, Sequist LV, Tong BC, Travis WD, Unger M, Yang SC. Lung cancer screening. Journal of the National Comprehensive Cancer Network : JNCCN 2012; 10(2):240-265
  • Hennon MW, Hylander B, Morrison C, Miller A, Groman A, Dexter E, Yendamuri S, Demmy TL, Adjei A, Reid M, Repasky E, Nwogu C. Predicting NSCLC outcomes based on tumor growth in SCID mice. Proceedings of the American Association for Cancer Research Annual Meeting 2011; 52:Abstract #1610
  • Nwogu CE, Groman A, Fahey D, Yendamuri S, Dexter E, Demmy TL, Miller A, Reid M. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer. Annals of thoracic surgery 2012; 93(5):1614-1619; discussion 1619-1620
  • Reid M, Yasko J. The role of biomarkers in cancer clinical trials. Seminars in oncology nursing 2012; 28(2):116-121
  • Bole C, Jayaprakash V, Platek M, Reid ME, Sullivan M, Loree T, Rigual N, Popat S, Moysich KB. Coffee and tea consumption and risk of head and neck cancers. American journal of epidemiology 2009; 169(Suppl. 11):S49
  • Yendamuri S, Caty L, Pine M, Adem S, Bogner P, Miller A, Demmy TL, Groman A, Reid M. Outcomes of sarcomatoid carcinoma of the lung: A Surveillance, Epidemiology, and End Results database analysis. Surgery 2012; 152(3):397-402
  • Zornosa C, Vandergrift JL, Kalemkerian GP, Ettinger DS, Rabin MS, Reid M, Otterson GA, Koczywas M, D'Amico TA, Niland JC, Mamet R, Pisters KM. First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions. Journal of the National Comprehensive Cancer Network : JNCCN 2012; 10(7):847-856
Source URL (retrieved on 05/23/2013 - 8:24am): http://www.roswellpark.org/mary-reid